Axsome Therapeutics
AXSM
AXSM
184 hedge funds and large institutions have $1.31B invested in Axsome Therapeutics in 2021 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 64 increasing their positions, 52 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
33% less capital invested
Capital invested by funds: $1.95B → $1.31B (-$643M)
74% less call options, than puts
Call options by funds: $14.1M | Put options by funds: $53.6M
Holders
184
Holding in Top 10
3
Calls
$14.1M
Puts
$53.6M
Top Buyers
| 1 | +$19.6M | |
| 2 | +$8.26M | |
| 3 | +$5.29M | |
| 4 |
Millennium Management
New York
|
+$4.94M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.56M |
Top Sellers
| 1 | -$23.3M | |
| 2 | -$17.8M | |
| 3 | -$15.1M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$13.6M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$13.4M |